Formulary Chapter 5: Infections - Full Chapter
|
05.03.01 |
Nucleoside reverse transcriptase inhibitors |
|
|
05.03.01 |
Protease inhibitors |
|
|
05.03.01 |
Non-nucleoside reverse transcriptase inhibitors |
|
|
05.03.01 |
Other antiretrovirals |
|
|
05.03.01 |
Pharmacokinetic enhancers of anti-retrovirals |
|
|
05.03.01 |
Combination Products |
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
|
|